Best stocks to buy today: Stock recommendations for May 7, 2026 – Checklist –

summit Stock market recommendations: Aakash K Hindocha, Vice President – WM Research, Nuvama Professional Clients Group has been selected Godrej Properties, At Mart Retailand Dr. Reddy’s Laboratories As top stock recommendations for May 7, 2026. The analyst also shared his forecast for Nifty, Bank Nifty. Let’s take a look:Show index: elegantThe index broke out of its consolidation range at 23750 – 24300 as global news flow acted as a tailwind in the second half of yesterday’s session. The 24,000 level is now likely to serve as a base for a bullish move towards 24,770/25,000.

It has broken out of a two-week range, and an initial uptrend could unfold to a 500 pip higher target.Nifty BankBank Nifty has also come out of its sideways range for one week and the index has underperformed over the past week to Nifty while this underperformance seems to have ended now. The continuation leg can now be opened for another 1,000 pips on the upside to the 57,100 odd target.

Stock Recommendations:

Godrej Properties (Buy):

Godrej Properties is on the verge of breaking the 18-month sloping trend line which could mark the end of its ongoing 6-quarter correction that has eroded more than 50% of market capitalization from its all-time highs.

The stock is likely to gain further momentum given its weight on the Nifty Realty index and strength across the board on the index. Nifty Realty is the best ever sector index in terms of percentage increase from grass to current highs in this broader market recovery starting from FY27.V-Mart Retail (Buy):

An inverted head and shoulders pattern has appeared on the VMART daily charts. This is a textbook pattern formation since both shoulders in the pattern spent an equal amount of time forming it before it exploded.

The stock also closed at a 12-week high yesterday with results released today, and expectations have piled up on the table while price action points to a continued trend north.Dr. Reddy’s Laboratories (Buy):

The stock has broken out of an 18-month consolidation zone on the weekly charts with a breakout retest completed as well. With the Nifty Pharma index rising to all-time highs, there are strong tailwinds on all its components. DRREDDY has a ~10% weighting on the index and the rising 200 DMA is likely to act as smooth support going forward. Strong traction is likely to unfold once the stock starts trading above the 1325-1330 region.

(Disclaimer: Recommendations, opinions regarding stock market, other asset classes or personal finance management tips provided by experts are their own. These opinions do not represent the views of The Times Of India.)